A detailed history of Bay Colony Advisory Group, Inc D transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 34,550 shares of MRK stock, worth $3.81 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
34,550
Previous 34,885 0.96%
Holding current value
$3.81 Million
Previous $4.6 Million 7.08%
% of portfolio
0.74%
Previous 0.83%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$123.8 - $132.96 $41,473 - $44,541
-335 Reduced 0.96%
34,550 $4.28 Million
Q1 2024

Apr 30, 2024

BUY
$113.24 - $131.95 $566 - $659
5 Added 0.01%
34,885 $4.6 Million
Q4 2023

Jan 29, 2024

BUY
$100.18 - $109.02 $196,252 - $213,570
1,959 Added 5.95%
34,880 $3.8 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $101,714 - $112,958
-988 Reduced 2.91%
32,921 $3.39 Million
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $128,485 - $140,043
-1,183 Reduced 3.37%
33,909 $3.91 Million
Q1 2023

Apr 27, 2023

SELL
$102.94 - $114.86 $236,967 - $264,407
-2,302 Reduced 6.16%
35,092 $3.73 Million
Q4 2022

Feb 01, 2023

BUY
$87.44 - $112.11 $6,645 - $8,520
76 Added 0.2%
37,394 $4.15 Million
Q3 2022

Oct 27, 2022

BUY
$84.53 - $94.96 $162,720 - $182,798
1,925 Added 5.44%
37,318 $3.21 Million
Q2 2022

Aug 08, 2022

BUY
$83.49 - $94.64 $51,930 - $58,866
622 Added 1.79%
35,393 $3.16 Million
Q1 2022

Apr 28, 2022

BUY
$73.51 - $82.4 $285,071 - $319,547
3,878 Added 12.55%
34,771 $2.85 Million
Q4 2021

Jan 28, 2022

BUY
$72.28 - $90.54 $37,947 - $47,533
525 Added 1.73%
30,893 $2.37 Million
Q3 2021

Nov 02, 2021

BUY
$71.68 - $78.83 $30,033 - $33,029
419 Added 1.4%
30,368 $2.28 Million
Q2 2021

Jul 22, 2021

BUY
$70.31 - $77.77 $120,511 - $133,297
1,714 Added 6.07%
29,949 $2.33 Million
Q1 2021

May 13, 2021

BUY
$68.86 - $81.11 $1.04 Million - $1.23 Million
15,163 Added 116.0%
28,235 $2.18 Million
Q4 2020

Feb 02, 2021

BUY
$71.77 - $79.65 $43,851 - $48,666
611 Added 4.9%
13,072 $1.07 Million
Q3 2020

Nov 25, 2020

BUY
$73.18 - $82.95 $181,998 - $206,296
2,487 Added 24.93%
12,461 $1.03 Million
Q2 2020

Jul 23, 2020

BUY
$70.42 - $80.13 $68,518 - $77,966
973 Added 10.81%
9,974 $771,000
Q1 2020

Apr 17, 2020

BUY
$63.36 - $87.82 $4,498 - $6,235
71 Added 0.8%
9,001 $693,000
Q4 2019

Jan 28, 2020

SELL
$77.58 - $87.54 $625,527 - $705,835
-8,063 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$77.58 - $87.54 $692,789 - $781,732
8,930 New
8,930 $801,000
Q3 2019

Oct 25, 2019

BUY
$76.08 - $82.93 $308,504 - $336,281
4,055 Added 101.17%
8,063 $679,000
Q2 2019

Jul 17, 2019

SELL
$69.84 - $81.59 $30,170 - $35,246
-432 Reduced 9.73%
4,008 $336,000
Q1 2019

Apr 30, 2019

BUY
$69.58 - $79.36 $70,206 - $80,074
1,009 Added 29.41%
4,440 $367,000
Q4 2018

Jan 29, 2019

SELL
$65.24 - $75.71 $31,771 - $36,870
-487 Reduced 12.43%
3,431 $262,000
Q3 2018

Nov 05, 2018

BUY
$57.69 - $67.84 $21,979 - $25,847
381 Added 10.77%
3,918 $278,000
Q2 2018

Aug 09, 2018

BUY
$50.83 - $59.72 $179,785 - $211,229
3,537 New
3,537 $215,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $279B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bay Colony Advisory Group, Inc D Portfolio

Follow Bay Colony Advisory Group, Inc D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.